NPH — Antigen, Cartilage Oligomeric Matrix Protein (Comp) Class II

FDA Device Classification

FDA product code NPH covers "Antigen, Cartilage Oligomeric Matrix Protein (Comp)", a Class II medical device regulated under 21 CFR 866.5775. Submissions are reviewed by the Immunology panel.

Classification Details

Product Code
NPH
Device Class
Class II
Regulation Number
866.5775
Submission Type
Review Panel
IM
Medical Specialty
Immunology
Implant
No

Definition

COMP ELISA is a quantitative enzyme-linked immunosorbent assay for detecting COMP (Cartilage Oligomeric Matrix Protein) in patient sera. The presence of elevated levels, when considered in conjunction with other laboratory and clinical findings, aids in identifying aggressive destruction of joint tissue in Rheumatoid Arthritis.